Literature DB >> 35960354

Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance.

Stefan Tukaj1, Katja Bieber2, Wiebke Prüßmann3, Jasper N Prüßmann3, Enno Schmidt2,3, Detlef Zillikens3, Ralf J Ludwig2,3, Michael Kasperkiewicz4.   

Abstract

Autoimmune bullous disease autoantibodies, particularly including bullous pemphigoid (BP)-related anti-BP180-NC16A IgG, have been reported in a small subset of healthy individuals, but information about associated factors is lacking. We hypothesized that an abnormal status of immunomodulatory vitamin D could play a role in anti-BP180-NC16A autoantibody reactivity in healthy persons. In addition, we aimed to evaluate the cytokine profile associated with these autoantibodies. Plasma samples from 34 anti-BP180-NC16A IgG-reactive and 85 anti-BP180-NC16A IgG-negative healthy blood donors were tested for levels of 25-hydroxyvitamin D [25(OH)D] and a wide range of cytokines (IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, IL-17A, IL-17F, IL-21, IL-22, IFN-γ, and TNF-α). We observed that anti-BP180-NC16A IgG-reactive healthy subjects had significantly lower plasma 25(OH)D levels and about a two-fold higher rate of vitamin D deficiency (< 20 ng/ml) compared to anti-BP180-NC16A IgG-negative healthy persons. In addition, anti-BP180-NC16A IgG-positive samples were characterized by significantly higher levels of IL-2, IL-5, IL-9, IL-10, and IL-13 which were, however, not significantly associated with the vitamin D levels. Our results indicate that healthy individuals with BP autoantibody reactivity share similarities with BP patients regarding the vitamin D status and cytokine profile (i.e., marked hypovitaminosis D and Th2 predominance), which may have pathophysiologic implications.
© 2022. The Author(s).

Entities:  

Keywords:  25(OH)D; Bullous pemphigoid; Cytokine; Th2; Vitamin D

Year:  2022        PMID: 35960354     DOI: 10.1007/s00403-022-02386-4

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.033


  20 in total

1.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

Review 2.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

3.  Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus.

Authors:  Lauren L Ritterhouse; Sherry R Crowe; Timothy B Niewold; Diane L Kamen; Susan R Macwana; Virginia C Roberts; Amy B Dedeke; John B Harley; R Hal Scofield; Joel M Guthridge; Judith A James
Journal:  Ann Rheum Dis       Date:  2011-05-17       Impact factor: 19.103

4.  Co-occurrence of autoantibodies in healthy blood donors.

Authors:  Jasper Prüßmann; Wiebke Prüßmann; Andreas Recke; Kristin Rentzsch; David Juhl; Reinhard Henschler; Susen Müller; Peter Lamprecht; Enno Schmidt; Elena Csernok; Siegfried Görg; Winfried Stöcker; Detlef Zillikens; Saleh M Ibrahim; Ralf J Ludwig
Journal:  Exp Dermatol       Date:  2014-07       Impact factor: 3.960

5.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

Authors:  Melissa R Arbuckle; Micah T McClain; Mark V Rubertone; R Hal Scofield; Gregory J Dennis; Judith A James; John B Harley
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

6.  Association between Vitamin D Deficiency and Antinuclear Antibodies in Middle-Aged and Older U.S. Adults.

Authors:  Helen C S Meier; Dale P Sandler; Eleanor M Simonsick; Christine G Parks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-19       Impact factor: 4.254

7.  Vitamin D in autoimmune bullous disease.

Authors:  Stefan Tukaj
Journal:  Acta Biochim Pol       Date:  2020-02-12       Impact factor: 2.149

8.  A retrospective review of autoimmune bullous disease antibody positivity before clinical symptoms.

Authors:  Eli Raneses; Meagan McGinley Simpson; Alexandra Rosenberg; Marcedes Coffman; Jon Meyerle
Journal:  J Am Acad Dermatol       Date:  2021-02-04       Impact factor: 11.527

9.  Prevalence of pemphigus and pemphigoid autoantibodies in the general population.

Authors:  Wiebke Prüßmann; Jasper Prüßmann; Hiroshi Koga; Andreas Recke; Hiroaki Iwata; David Juhl; Siegfried Görg; Reinhard Henschler; Takashi Hashimoto; Enno Schmidt; Detlef Zillikens; Saleh M Ibrahim; Ralf J Ludwig
Journal:  Orphanet J Rare Dis       Date:  2015-05-15       Impact factor: 4.123

10.  Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis.

Authors:  Miao Yang; Haijing Wu; Ming Zhao; Hai Long; Qianjin Lu
Journal:  J Dermatolog Treat       Date:  2020-08-26       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.